Search

everythinglearnresearchcommunity

for

Search:↓

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Vorasidenib can cause unusual hair growth.

Ectopic acanthosis nigricans can occur at surgical sites due to skin graft mismatches.

TPO antibodies can help identify hypothyroid patients who still have symptoms despite normal TSH levels.

Gefitinib can cause hair loss without scarring.

Tongue cancer cells show more plectin-1 than non-cancer cells, but both have similar levels of trichohyalin.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Using thigh skin, doctors successfully rebuilt a woman's scalp after removing a large tumor, with no tumor return after 8 months.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Atrichia with papular lesions causes irreversible hair loss from infancy and is often misdiagnosed.

Hodgkin's lymphoma can show up as hair loss.

Trichoblastoma in the breast can be mistaken for cancer, so expert review is crucial to avoid misdiagnosis.

PTCH gene mutations contribute to basal cell carcinoma development.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

TURP specimens should be checked for various tumors, not just common prostate issues.

Enlarged sweat gland ducts may indicate scarring hair loss.

A chest X-ray can effectively diagnose ectopic ACTH secretion from lung tumors.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Thyroid disorders are linked to skin issues and autoimmune skin diseases.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

A 20-month-old girl had a rare adrenal tumor removed successfully, with no recurrence for 10 years.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.